{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:26:20Z","timestamp":1790331980895,"version":"4.1.0"},"reference-count":51,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cholangiocarcinoma is an epithelial malignancy arising in the region between the intrahepatic bile ducts and the ampulla of Vater at the distal end of the common bile duct. The effect of current chemotherapy regimens against cholangiocarcinoma is limited, and the prognosis of patients with cholangiocarcinoma is poor. Aberrant DNA methylation and histone modification induce silencing of tumor suppressor genes and chromosomal instability during carcinogenesis. Studies have shown that the tumor suppressor genes and microRNAs (miRNAs) including MLH1, p14, p16, death-associated protein kinase (DAPK), miR-370 and miR-376c are frequently methylated in cholangiocarcinoma. Silencing of these tumor suppressor genes and miRNAs plays critical roles in the initiation and progression of cholangiocarcinoma. In addition, recent studies have demonstrated that DNA methylation inhibitors induce expression of endogenous retroviruses and exert the anti-tumor effect of via an anti-viral immune response. Aberrant DNA methylation of tumor suppressor genes and miRNAs could be a powerful biomarker for the diagnosis and treatment of cholangiocarcinoma. Epigenetic therapy with DNA methylation inhibitors holds considerable promise for the treatment of cholangiocarcinoma through the reactivation of tumor suppressor genes and miRNAs as well as the induction of an anti-viral immune response.<\/jats:p>","DOI":"10.3390\/ijms18061111","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T11:14:33Z","timestamp":1495538073000},"page":"1111","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma"],"prefix":"10.3390","volume":"18","author":[{"given":"Toshiaki","family":"Nakaoka","sequence":"first","affiliation":[{"name":"Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetsugu","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nbt.1678","article-title":"Epigenetic modifications as therapeutic targets","volume":"28","author":"Kelly","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.59.061606.095816","article-title":"Cancer epigenetics: Modifications, screening, and therapy","volume":"59","author":"Saito","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome-biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/hepr.12147","article-title":"Alterations of epigenetics and microRNA in hepatocellular carcinoma","volume":"44","author":"Saito","year":"2014","journal-title":"Hepatol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ccr.2006.04.020","article-title":"Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells","volume":"9","author":"Saito","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4161\/cc.5.19.3340","article-title":"Epigenetic activation of tumor suppressor microRNAs in human cancer cells","volume":"5","author":"Saito","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/cas.12498","article-title":"Silencing of microRNA-122 is an early event during hepatocarcinogenesis from non-alcoholic steatohepatitis","volume":"105","author":"Takaki","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12016-013-8401-z","article-title":"Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: A critical review","volume":"47","author":"Saito","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_12","first-page":"233","article-title":"Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor","volume":"26","author":"Wakabayashi","year":"2005","journal-title":"Int. J. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1038\/oncsis.2014.17","article-title":"Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells","volume":"3","author":"Hibino","year":"2014","journal-title":"Oncogenesis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2004.06.020","article-title":"Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma","volume":"217","author":"Limpaiboon","year":"2005","journal-title":"Cancer Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.MP.0000038461.80167.34","article-title":"Microsatellite instability in intraductal papillary neoplasms of the biliary tract","volume":"15","author":"Abraham","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/ijc.29039","article-title":"The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers","volume":"136","author":"Vedeld","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/gast.2002.36021","article-title":"p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma","volume":"123","author":"Taniai","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/gut.51.2.253","article-title":"INK4a-ARF alterations in liver cell adenoma","volume":"51","author":"Tannapfel","year":"2002","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7819-10-5","article-title":"Correlation between promoter methylation of p14(ARF), TMS1\/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma","volume":"10","author":"Xiaofang","year":"2012","journal-title":"World J. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/147323001204000107","article-title":"Targeted drug regulation on methylation of p53-BAX mitochondrial apoptosis pathway affects the growth of cholangiocarcinoma cells","volume":"40","author":"Liu","year":"2012","journal-title":"J. Int. Med. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.clinre.2013.11.004","article-title":"si-DNMT1 restore tumor suppressor genes expression through the reversal of DNA hypermethylation in cholangiocarcinoma","volume":"38","author":"Xiang","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_22","first-page":"407","article-title":"Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma","volume":"6","author":"Liu","year":"2007","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jmoldx.2012.01.014","article-title":"Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity","volume":"14","author":"Shin","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1158\/0008-5472.CAN-06-2130","article-title":"Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression","volume":"66","author":"Wehbe","year":"2006","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"18905","DOI":"10.18632\/oncotarget.4305","article-title":"Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","article-title":"Evolution of the cancer stem cell model","volume":"14","author":"Kreso","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1158\/1940-6207.CAPR-13-0104","article-title":"Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors","volume":"6","author":"Sriraksa","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0016-5107(94)70155-5","article-title":"Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies","volume":"40","author":"Lichtenstein","year":"1994","journal-title":"Gastrointest. Endosc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2005.03.040","article-title":"Cholangiocarcinoma","volume":"128","author":"Lazaridis","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: A common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2004-828890","article-title":"The molecular pathogenesis of cholangiocarcinoma","volume":"24","author":"Berthiaume","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"Spirli","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2017.04.011","article-title":"Epigenetics: The third pillar of nitric oxide signaling","volume":"121","author":"Socco","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Nakamura, K., Nakabayashi, K., Htet Aung, K., Aizawa, K., Hori, N., Yamauchi, J., Hata, K., and Tanoue, A. (2015). DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120545"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3727\/096504008785114110","article-title":"Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma","volume":"17","author":"Uhm","year":"2008","journal-title":"Oncol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1172\/JCI42275","article-title":"hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing","volume":"120","author":"Lee","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.23381","article-title":"MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes","volume":"51","author":"Braconi","year":"2010","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.onc.1210648","article-title":"Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes","volume":"27","author":"Meng","year":"2008","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Iwaki, J., Kikuchi, K., Mizuguchi, Y., Kawahigashi, Y., Yoshida, H., Uchida, E., and Takizawa, T. (2013). MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069496"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/carcin\/bgv060","article-title":"Reducing DNA methylation suppresses colon carcinogenesis by inducing tumor cell differentiation","volume":"36","author":"Hatano","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2005.01191.x","article-title":"Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis","volume":"26","author":"Abiru","year":"2006","journal-title":"Liver Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1099\/vir.0.000017","article-title":"Activation of the innate immune response by endogenous retroviruses","volume":"96","author":"Hurst","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"25311","DOI":"10.1038\/srep25311","article-title":"Inhibition of DNA Methylation Suppresses Intestinal Tumor Organoids by Inducing an Anti-Viral Response","volume":"6","author":"Saito","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"Francies","year":"2015","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.18632\/oncotarget.1542","article-title":"Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine","volume":"4","author":"Wrangle","year":"2013","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10549-014-3133-1","article-title":"Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: A real-world multicenter observational analysis. The RETROHER study","volume":"147","author":"Vici","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Raynal, N.J., Da Costa, E.M., Lee, J.T., Gharibyan, V., Ahmed, S., Zhang, H., Sato, T., Malouf, G.G., and Issa, J.J. (2016). Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome. Mol. Cancer Ther.","DOI":"10.1158\/1535-7163.MCT-16-0588"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/6\/1111\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:36:39Z","timestamp":1760207799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/6\/1111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["ijms18061111"],"URL":"https:\/\/doi.org\/10.3390\/ijms18061111","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201705.0127.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]}}}